CoreAge Rx
Direct medication pricing without a separate membership charge
Semaglutide from $99/month; tirzepatide from $149/month
Read the evidence and terms →Providers, care platforms and two manufacturer products, each reviewed from current official public sources. Search the details that matter to your comparison.
33 of 33 reviews
Direct medication pricing without a separate membership charge
Semaglutide from $99/month; tirzepatide from $149/month
Read the evidence and terms →Low-price categories differ from the branded listings
Headlines from $89 GLP-1 and $149 GLP-1/GIP
Read the evidence and terms →A discount amount is not a monthly treatment price
First-order savings advertised; full total not established
Read the evidence and terms →Medication inclusion does not settle every clinical or lab service
Complete selected-plan price requires clarification
Read the evidence and terms →Weight management appears within a wider medical catalog
Selected GLP-1 item and price require clarification
Read the evidence and terms →Brand access and compounds should remain separate
Exact selected-plan total requires clarification
Read the evidence and terms →A category name does not establish a branded preparation
Headlines $79 GLP-1 injection; $129 GLP-1/GIP
Read the evidence and terms →An employer program is not a consumer medication subscription
Employer arrangement; no individual cash-pay price established
Read the evidence and terms →The first month and later tier prices differ sharply
Semaglutide $49 introduction, then $212/month
Read the evidence and terms →Understand which plan includes compounded medication
Advertised from $99/month with insurance or $169 cash pay
Read the evidence and terms →The “buy three” message describes a four-month commitment
Four-month membership promotion has prepaid renewal terms
Read the evidence and terms →The platform itself is not the healthcare provider
Selected medicine and recurring-plan total need clarification
Read the evidence and terms →Nutrition services do not turn drug trials into platform results
Exact selected medication price not established
Read the evidence and terms →A women-focused service is not a women-specific treatment trial
Numerical selected-plan price not supplied in the reviewed text
Read the evidence and terms →Check the plan behind the all-inclusive message
Published inclusion claims; exact selected price needs confirmation
Read the evidence and terms →The pill price excludes the membership
Wegovy pill from $149; separate membership $39 then $149
Read the evidence and terms →Distinguish the membership team from the prescription
Membership $75/month; medication pricing separate to clarify
Read the evidence and terms →A promotional headline and a product format need separate checks
Headline offers $88 GLP-1 and $188 GLP-1/GIP
Read the evidence and terms →General primary care is broader than the weight program
Weight-specific total needs the selected-plan price
Read the evidence and terms →Separate prescribing care from optional coaching benefits
A reliable selected-plan total was not established
Read the evidence and terms →A medication-card figure is not automatically a complete plan total
Medication cards from $60 semaglutide and $90 tirzepatide
Read the evidence and terms →Program names change both price and what is included
GLP-1Rx $129 start, then $249/month billed quarterly
Read the evidence and terms →A primary-care visit is different from a bundled medicine subscription
Appointment and medicine costs need an individual quote
Read the evidence and terms →Wellness advisors and physicians have different responsibilities
A complete selected-plan price was not established
Read the evidence and terms →Month-to-month messaging needs the actual selected-plan terms
Exact recurring price not established in the reviewed opening
Read the evidence and terms →Separate the membership from the prescription bill
Membership $39 first month, then $149/month; medicine extra
Read the evidence and terms →A starting offer and a guarantee need different reading
Semaglutide from $159; tirzepatide from $239
Read the evidence and terms →Low figures require the exact price-lock and refund conditions
Promotional semaglutide $69; tirzepatide $119
Read the evidence and terms →Annual prepayment changes the headline comparison
Annual plan equivalents: semaglutide $99; tirzepatide $125/month
Read the evidence and terms →Different Wegovy forms have different approved populations
Manufacturer savings and eligibility terms vary
Read the evidence and terms →Clinical access and the behavior program have separate evidence
Med+ introductory membership $25; medicine separate
Read the evidence and terms →Separate compounded offers from broad approval language
Selected weight-plan price not established
Read the evidence and terms →Branded tirzepatide is different from a compounded offer
Self-pay savings are product- and eligibility-specific
Read the evidence and terms →